|
|
|
Insider
Information: |
Bergstrom Donald A |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
527,427 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,502,115 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
527,427 |
|
|
Total
Value |
$3,502,115 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-591.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mersana Therapeutics, Inc. |
MRSN |
|
|
0 |
|
0 |
Premium* |
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
527,427 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RLAY |
Relay Therapeutics, Inc. |
See RemarksOfficer |
|
2020-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,566 |
|
- |
|
RLAY |
Relay Therapeutics, Inc. |
See Remarks |
|
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
34,999 |
133,565 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
64,950 |
109,920 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
160,390 |
246,276 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
534,056 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
See Remarks |
|
2021-06-16 |
4 |
OE |
$4.12 |
$174,037 |
D/D |
42,242 |
119,483 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-02-22 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
117,920 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-03-01 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
102,926 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-03-10 |
4 |
OE |
$4.12 |
$41,200 |
D/D |
10,000 |
104,926 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-03-24 |
4 |
OE |
$4.12 |
$41,200 |
D/D |
10,000 |
104,926 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-04-01 |
4 |
OE |
$4.12 |
$74,160 |
D/D |
18,000 |
112,304 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-05-02 |
4 |
OE |
$4.12 |
$53,560 |
D/D |
13,000 |
105,493 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-06-24 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
100,493 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-07-06 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
99,494 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-08-05 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
97,659 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-08-24 |
4 |
OE |
$4.12 |
$61,800 |
D/D |
15,000 |
104,659 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-09-01 |
4 |
OE |
$4.12 |
$33,372 |
D/D |
8,100 |
97,759 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-09-02 |
4 |
OE |
$4.12 |
$20,188 |
D/D |
4,900 |
94,559 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-09-08 |
4 |
OE |
$4.12 |
$103,000 |
D/D |
25,000 |
114,659 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-10-03 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
96,683 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2022-11-01 |
4 |
OE |
$4.12 |
$32,960 |
D/D |
8,000 |
94,866 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2023-10-30 |
4 |
S |
$6.03 |
$20,810 |
D/D |
(3,451) |
235,033 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2024-04-29 |
4 |
S |
$6.38 |
$17,137 |
D/D |
(2,686) |
527,427 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2024-03-27 |
4 |
S |
$7.70 |
$5,891 |
D/D |
(765) |
530,113 |
0 |
% |
|
RLAY |
Relay Therapeutics, Inc. |
President, R&D |
|
2023-09-27 |
4 |
S |
$8.38 |
$5,430 |
D/D |
(648) |
238,484 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|